Alpha Cognition Inc. Operating Income
Alpha Cognition Inc. (ACOG) reported Operating Income of -$7.76 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-13
- Alpha Cognition Inc. operating income (loss) for the quarter ending 2026-06-30 was -$7.76M.
- Alpha Cognition Inc. operating income (loss) for the quarter ending 2026-03-31 was -$8.10M.
- Alpha Cognition Inc. operating income (loss) for the quarter ending 2025-12-31 was -$7.93M.
- Alpha Cognition Inc. operating income (loss) for the quarter ending 2025-09-30 was -$5.31M.
- Alpha Cognition Inc. operating income (loss) for fiscal 2025 was -$22.66M.
- Alpha Cognition Inc. operating income (loss) for fiscal 2024 was -$12.01M.
- Alpha Cognition Inc. operating income (loss) for fiscal 2023 was -$9.94M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$7.76M 10-Q · filed 2026-08-13 | -$15.85M 10-Q · filed 2026-08-13 | -$23.78M derived: sum of 3 quarters · filed 2026-08-13 | -$29.09M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | -$8.10M 10-Q · filed 2026-05-14 | -$16.02M derived: sum of 2 quarters · filed 2026-05-14 | -$21.33M derived: sum of 3 quarters · filed 2026-05-14 | -$29.78M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | -$7.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$13.24M derived: sum of 2 quarters · filed 2026-03-31 | -$21.68M derived: sum of 3 quarters · filed 2026-08-13 | -$22.66M 10-K · filed 2026-03-31 | |||
| 2025-09-30 | -$5.31M 10-Q · filed 2025-11-13 | -$13.76M derived: sum of 2 quarters · filed 2026-08-13 | -$14.74M 10-Q · filed 2025-11-13 | -$19.86M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | -$8.45M 10-Q · filed 2026-08-13 | -$5.74M 10-Q · filed 2025-08-14 | -$11.85M 10-Q · filed 2026-08-13 | -$9.42M 10-Q · filed 2025-08-14 | -$14.54M derived: sum of 3 quarters · filed 2026-08-13 | -$17.03M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | -$3.40M 10-Q · filed 2026-05-14 | -$3.69M 10-Q · filed 2025-05-15 | -$6.10M derived: sum of 2 quarters · filed 2026-05-14 | -$8.58M derived: sum of 3 quarters · filed 2026-05-14 | -$11.01M derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | -$2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$5.18M derived: sum of 2 quarters · filed 2026-03-31 | -$7.60M derived: sum of 3 quarters · filed 2026-03-31 | -$12.01M 10-K · filed 2026-03-31 | -$11.86M 10-K · filed 2025-03-31 | ||
| 2024-09-30 | -$2.49M 10-Q · filed 2025-11-13 | -$4.91M derived: sum of 2 quarters · filed 2025-11-13 | -$9.32M 10-Q · filed 2025-11-13 | -$11.74M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | -$2.42M 10-Q · filed 2025-08-14 | -$6.83M 10-Q · filed 2025-08-14 | -$9.25M derived: sum of 3 quarters · filed 2025-08-14 | -$12.02M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | -$4.41M 10-Q · filed 2025-05-15 | -$6.83M derived: sum of 2 quarters · filed 2025-05-15 | -$9.60M derived: sum of 3 quarters · filed 2025-05-15 | -$12.33M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -$2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$5.19M derived: sum of 2 quarters · filed 2025-03-31 | -$7.91M derived: sum of 3 quarters · filed 2025-03-31 | -$9.94M 10-K · filed 2025-03-31 | |||
| 2023-09-30 | -$2.77M 10-Q · filed 2024-11-14 | -$5.49M derived: sum of 2 quarters · filed 2024-11-14 | -$7.52M 10-Q · filed 2024-11-14 | ||||
| 2023-06-30 | -$2.73M 10-Q · filed 2024-08-12 | -$4.71M 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |